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ABSTRACT
Low extracellular calcium (Ca2) promotes release of parathyroid hormone (PTH), which acts on multiple
organs to maintain overall Ca2 balance. In the distal part of the nephron, PTH stimulates active Ca2
reabsorption via the adenylyl cyclase–cAMP–protein kinase A (PKA) pathway, but the molecular target
of this pathway is unknown. The transient receptor potential vanilloid 5 (TRPV5) channel constitutes the
luminal gate for Ca2 entry in the distal convoluted tubule and has several putative PKA phosphorylation
sites. Here, we investigated the effect of PTH-induced cAMP signaling on TRPV5 activity. Using fluo-
rescence resonance energy transfer, we studied cAMP and Ca2 dynamics during PTH stimulation of
HEK293 cells that coexpressed the PTH receptor and TRPV5. PTH increased cAMP levels, followed by
a rise in TRPV5-mediated Ca2 influx. PTH (1 to 31) and forskolin, which activate the cAMP pathway,
mimicked the stimulation of TRPV5 activity. Remarkably, TRPV5 activation was limited to conditions of
strong intracellular Ca2 buffering. Cell surface biotinylation studies demonstrated that forskolin did not
affect TRPV5 expression on the cell surface, suggesting that it alters the single-channel activity of a fixed
number of TRPV5 channels. Application of the PKA catalytic subunit, which phosphorylated TRPV5,
directly increased TRPV5 channel open probability. Alanine substitution of threonine-709 abolished both
in vitro phosphorylation and PTH-mediated stimulation of TRPV5. In summary, PTH activates the
cAMP-PKA signaling cascade, which rapidly phosphorylates threonine-709 of TRPV5, increasing the
channel’s open probability and promoting Ca2 reabsorption in the distal nephron.
J Am Soc Nephrol 20: 1693–1704, 2009. doi: 10.1681/ASN.2008080873
Calcium (Ca2) is essential for numerous physio-
logic functions andmany cellular processes, includ-
ing signal transduction, cell motility, andmorphol-
ogy.1,2 The bodymaintains extracellular Ca2 levels
within a narrow range. Slight perturbations in Ca2
homeostasis are detected by the Ca2-sensing re-
ceptor, located in the parathyroid glands.3 Low ex-
tracellular Ca2 levels inhibit Ca2-sensing recep-
tor activity, causing the release of parathyroid
hormone (PTH) into the circulation.3,4 In the kid-
ney, PTH reduces Ca2 excretion by stimulating
Ca2 reabsorption from the distal part of the
nephron.5 Secreted PTH consists of 84 amino acids.
Upon binding to the PTH receptor (PTH1R), it is
able to activate both protein kinase C (PKC), via
phospholipase C (PLC), and adenylyl cyclase-
cAMP, depending on the cell type.6,7 Activation of
the latter pathway requires the first two residues
within the amino-terminus of PTH. Consequently,
PTH (3 to 34) does not affect basal cAMP levels in
contrast to PTH (1 to 34).8–10 Use of full-length
PTH and these fragments has implicated both path-
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ways in PTH-induced stimulation of renal Ca2 reabsorp-
tion.5,7,11,12
The transient receptor potential vanilloid 5 (TRPV5) Ca2
channel constitutes the apical entry gate for active (transcellu-
lar) Ca2 reabsorption from the distal part of the nephron.13,14
It is, therefore, a likely target of PTH. Support for this notion is
provided by the observation that long-term exposure to PTH
enhances TRPV5 activity via two distinct mechanisms. PTH
increases TRPV5 expression15 and causes accumulation of the
channel at the plasma membrane. The latter effect involves
PLC signaling and a subsequent PKC-dependent phosphory-
lation.16 In contrast, the molecular target for the adenylyl cy-
clase–cAMP–protein kinase A (PKA) pathway activated by
PTH has not been identified. Using ex vivo models of active
Ca2 reabsorption, PTH-induced cAMP signaling was dem-
onstrated to be essential for rapid stimulation of luminal Ca2
uptake.5,11,17,18 Interestingly, primary cultures of isolated rab-
bit connecting tubules (CNT) and cortical collecting duct cells,
which express endogenous TRPV5, displayed increased trans-
cellular Ca2 transport after exposure to forskolin or cAMP-
elevating hormones, including PTH.12,19,20 Thus, despite the
large number of studies investigating the role of PTH in renal
Ca2 handling, the molecular mechanism connecting the
cAMP pathway with subsequent stimulation of active Ca2
reabsorption has not yet been determined. Because TRPV5 has
several putative PKAphosphorylation sites and is fundamental
to renal Ca2 handling, this channel is a likely target for PTH
stimulation via the cAMP-signaling pathway.
The aim of this study, therefore, was to elucidate the poten-
tial role of TRPV5 in PTH-induced stimulation of transcellular
Ca2 reabsorption via cAMP-PKA signaling. First, we con-
firmed that PTH increases 45Ca2 influx in HEK293 cells co-
expressing TRPV5 and PTH1R. Next, after exposure to PTH
we monitored intracellular Ca2, phosphatidylinositol-4,5-
bisphosphate (PIP2) and cAMP levels in this model system by
dynamic fluorescence resonance energy transfer (FRET) as-
says. Furthermore, we investigated the consequence of forsko-
lin-induced cAMP elevation on TRPV5 function. Finally, we
determined TRPV5 cell surface abundance and single channel
activity after activation of the cAMP-PKA signaling cascade.
RESULTS
PTH Induces a Sustained Increase in TRPV5-Mediated
Ca2 Influx
For studying the role of PTH on TRPV5 activity, TRPV5 and
PTH1R were coexpressed in HEK293 cells and treated for 10
min with 10 nM PTH, and, subsequently, we determined the
45Ca2 influx rate. Because TRPV5 is known to be rapidly in-
activated by elevated intracellular Ca2 levels,21 we pretreated
the cells with 25 M 1,2-bis-(2-aminophenoxy)ethane-
N,N,N,N-tetra-acetic acid-acetoxymethyl ester (BAPTA-
AM), a cell-permeable Ca2 buffer. Under these conditions,
we observed a significant enhancement of TRPV5 activity by
PTH (Figure 1A). Ruthenium red, a selective blocker of
TRPV5,22 inhibited 45Ca2 uptake under control and PTH-
stimulated conditions (Figure 1A).
To measure the acute effect of PTH on TRPV5 function,
HEK293 cells were transfected with yellow cameleon 2.1, a
FRET sensor that detects free intracellular Ca2. Figure 1B
shows a typical example of a calibrated FRET trace. FRET was
normalized to a minimum value, obtained after addition of 4
mM BAPTA (point B) in combination with 5 M of the Ca2
Figure 1. PTH rapidly induces a sustained stimula-
tion of TRPV5-mediated Ca2 influx. (A) 45Ca2 in-
flux in HEK293 cells transiently coexpressing PTH1R
and TRPV5, pretreated for 30 min with 25 M
BAPTA-AM. All procedures were performed at
37C, and PTH or DMSO solvent (CTR) was admin-
istered simultaneously with 45Ca2. *P  0.05 ver-
sus CTR. TRPV5-specific 45Ca2 influx was deter-
mined by addition of 10 M ruthenium red (RR). (B)
Representative trace of intracellular Ca2 upon PTH
stimulation using yellow cameleon 2.1 as a FRET
sensor. (C) Basal calibrated Ca2 levels in HEK293
cells transfected with mock (n  8) and TRPV5 (n 
9). *P  0.05 versus mock. (D) Average trace of
intracellular Ca2 levels of TRPV5 upon treatment
with PTH (n  9). (Inset) Relative FRET Ca2 in-
crease from basal to PTH-stimulated conditions, as
shown by time periods “A” and “B,” respectively.
*Significant difference (P  0.05) from basal condi-
tions.
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ionophore ionomycin (point C), and a maximum value was
reached after addition (point D) of 8 mMCaCl2. These exper-
iments revealed that basal intracellular Ca2 concentrations in
HEK293 cells expressing wild-type TRPV5 (TRPV5-WT) were
significantly higher than mock-transfected cells (Figure 1C).
PTH stimulation of TRPV5-expressing cells resulted in a fur-
ther steady increase of the intracellular Ca2 concentration,
starting 40 to 50 s after addition of PTH and leveling off after
approximately 3 min (Figure 1D). In the presence of PTH, the
intracellular Ca2 concentration was significantly greater than
under the control conditions, as shown in Figure 1D.
PTH-Induced Activation of the cAMP Signaling
Cascade Stimulates TRPV5
To study the role of PKC inPTH-dependent acute activation of
TRPV5, we used a TRPV5 mutant lacking all six putative PKC
consensus sites (TRPV5-PKC6)23. A previous study demon-
strated that two of these PKC consensus sites play a crucial role
in the PTH-induced accumulation of TRPV5 at the cell sur-
face.16 This long-term TRPV5 activation was shown to depend
on PLC signaling and subsequent PIP2 breakdown.23 Interest-
ingly, treatment of HEK293 cells coexpressing PTH1R and
TRPV5-PKC6 with PTH enhanced 45Ca2 influx to a similar
extent as TRPV5-WT (Figure 2A). Because these results sug-
gested the involvement of an alternative signaling pathway, we
used FRET sensors for intracellular PIP224 and cAMP.25 Figure
2B depicts a typical FRET trace for the PIP2 sensor under rest-
ing conditions (t  0 min) and during maximal stimulation
using 5 M ionomycin and 8 mM CaCl2 to activate Ca
2-
dependent PLCs.26 We did not detect PIP2 breakdown after
treatment with 10 nM PTH, using HEK293 cells with (n 6)
or without (n 4; data not shown) TRPV5 coexpression (Fig-
ure 2B). Using the Epac-based FRET sensor, the intracellular
cAMP levels were monitored in PTH-stimulated HEK293
cells. A representative trace is presented in Figure 2C. The
FRET results were expressed by normalizing traces between the
resting value (at t 0 min) and a maximum value, which was
induced by treatment with 50 M forskolin and 0.5 mM iso-
butylmethylxanthine. In Figure 2D, mean cAMP levels upon
addition of PTH are depicted. PTH induced a rapid elevation
of cAMP that reaches a plateau after 9 min. This stimulation
was 80 to 90% of the maximum FRET values.
To study the involvement of the cAMP pathway in PTH-
induced TRPV5 activation in more detail, we used different
PTH fragments. The biologic active part of PTH is compro-
mised by the first 34 amino acids. The first two residues of the
N-terminus are required for a cAMP response.10 Consistent
with a PTH-specific elevation in cAMP levels PTH (1 to 31), in
contrast to PTH (3 to 34), rapidly increased cAMP levels (Fig-
ure 2E). Compelling evidence for the crucial role of cAMP in
TRPV5 activation was gained bymeasuring intracellular Ca2.
PTH (1 to 31) treatment induced a sustained raise of intracel-
lular Ca2, which reached a maximal effect after approxi-
mately 3 min (Figure 2F). In contrast, PTH (3 to 34) did not
affect intracellular Ca2 concentrations (Figure 2F).
Forskolin Mimics the PTH-Dependent Activation of
TRPV5
We used forskolin to study directly the role of cAMP in the
regulation of TRPV5 channel activity. We determined the in-
flux of 45Ca2 in HEK293 cells transiently expressing TRPV5
treated with 10 M forskolin for 10 min. Forskolin signifi-
Figure 2. Dynamic effects of PTH and
its fragments on PIP2, cAMP, andCa
2
levels. (A) 45Ca2 uptake of HEK293
cells transiently coexpressing PTH1R
and TRPV5-PKC6 was performed as
previously performed with TRPV5-WT.
*P  0.05 versus CTR. (B) PIP2 re-
sponse upon PTH stimulation in cells
coexpressing PIP2 FRET sensors,
PTH1R, and TRPV5-WT. (C) Conse-
quence of PTH treatment on intracel-
lular cAMP response. (D and E) Aver-
age cAMP trace upon stimulation of
full-lengthPTH (n7;D) andPTH (1 to
31) (n  10) and PTH (3 to 34) (n  4;
E). (F) Average FRET data representing
intracellular Ca2 of cells expressing
TRPV5-WT upon stimulation with PTH
(1 to 31) (n 9) and PTH (3 to 34) (n
5). Ca2 levels during unstimulated (as
depicted by “A”) and forskolin-treated
conditions (time period “B”) for both
PTH fragments, as shown by inset fig-
ure. *P 0.05 versus basal conditions.
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cantly increased TRPV5 activity, fully mimicking PTH stimu-
lation (Figure 3A). Again, ruthenium red blocked TRPV5-me-
diated 45Ca2uptake under both control and forskolin-treated
conditions (Figure 3A). Subsequently, we investigated the po-
tential involvement of PKA in the activation of TRPV5, be-
cause forskolin is a widely known activator of this enzyme;
therefore, HEK293 cells transiently expressing TRPV5 were
pretreated for 30 min with 10 MH-89, a selective blocker of
PKA activity.27 This abolished the forskolin-induced stimula-
tion of TRPV5 activity (Figure 3B). To determine the specific-
ity of the PKA-mediated increase in TRPV5 activity, we used
the closely related epithelial Ca2 channel, TRPV6, known as
the luminal entry gate for intestinal Ca2 absorption.28 Acute
forskolin treatment did not alter TRPV6 activity in either the
presence or the absence of buffers to chelate intracellular Ca2
(Figure 3C), confirming that the forskolin-induced channel
activation is specific for TRPV5.
Under conditions lacking an intracellular buffer for Ca2,
forskolin did not noticeably affect TRPV5-mediated 45Ca2
influx (Figure 3D). PTH also failed to increase 45Ca2 influx
under these conditions (40 5 and 46 6 pmol/min per mg
for control and PTH, respectively; P  0.2). Next, we used
EDTA-acetoxymethyl ester (EDTA-AM), a buffer with rela-
tively slow Ca2-binding kinetics relative to BAPTA-AM,29 to
study further the role of Ca2 buffering in TRPV5 regulation
by forskolin. Pretreatment with EDTA-AM and subsequent
forskolin stimulation increased TRPV5 activity, although less
pronounced compared with BAPTA-AM pretreatment (Fig-
ure 3D). Importantly, the Ca2-binding protein calbindin-
D28K, which co-localizes with TRPV5 in renal tubular epithe-
lial cells,30,31 acts as a natural cytosolic Ca2 buffer. The
coexpression of calbindin-D28K inHEK293 cells also permitted
a significant increase of 45Ca2 influx upon forskolin treat-
ment (Figure 3D).
Next, we investigated the role of intracellular Ca2 on for-
skolin-induced activation of TRPV5 using patch-clamp analy-
sis. Forskolin did not alter TRPV5-mediated Na currents in
the ruptured whole-cell mode (Supplemental Figure 1); there-
fore, we further investigated TRPV5 regulation by amphoteri-
cin B–perforated patch-clamp analysis. In this configuration,
forskolin rapidly elevatedwhole-cell Na currents (Figure 3E).
Subsequently, we treated cells with BAPTA-AM. In compari-
son with untreated conditions, BAPTA-AM treatment did not
significantly increase the basalNa current (106 5%; n 13;
P  0.2), indicating that the basal intracellular Ca2 concen-
tration does not inhibit TRPV5 activity. Importantly,
BAPTA-AM pretreatment amplified the forskolin-mediated
stimulation of TRPV5 (Figure 3E).
Figure 3. Forskolin (FSK) specifically stimulates TRPV5
activity under Ca2-chelating conditions. (A) 45Ca2 up-
take of HEK293 cells transiently expressing TRPV5 and
pretreated for 30 min with 25 M BAPTA-AM. FSK was
administered simultaneously with 45Ca2. (B) Potential
role of PKA was investigated by 30 min of pretreatment
of 10 M H-89. (C) FSK effect on 45Ca2 uptake of
HEK293 cells transiently expressing TRPV6, pretreated
with 25 M BAPTA-AM and DMSO as a control. (D)
Both pretreatment of 25 M EDTA-AM and coexpres-
sion of calbindin-D28K (CaBP28K) enabled an FSK-in-
duced stimulation of TRPV5 function. (E) Amphotericin B
perforated whole-cell patch-clamp was used to study
Na currents of cells expressing TRPV5-WT. At t  2
min, cells were treated with 10 M FSK. For investiga-
tion of the effect of intracellular Ca2 on TRPV5 activity
by FSK, cells were treated with 100 M BAPTA-AM.
(Inset) Current increase of CTR (n 8), FSK (n 10), and
FSK  BAPTA-AM (n  11) after 14 min compared with
the current measured at t  2 min. *P  0.05 versus
CTR.
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PKA-Mediated TRPV5 Stimulation Depends on
Threonine Residue 709
Next, we inquired whether the forskolin-mediated TRPV5
stimulation was due to a direct phosphorylation of the channel
by PKA. To identify putative PKA consensus sites in TRPV5,
we used the prediction server NetPhosk (http://www.cbs.
dtu.dk/services). Computational analysis of the TRPV5 amino
acid sequence of four different mammalian species resulted in
the identification of three highly conserved PKA consensus
sites (Figure 4A). Of the putative phospho-residues, one serine
was located in the N-tail (S142), whereas the C-tail har-
bored the other putative sites, another serine and a threo-
nine residue (S680 and T709). Using site-directed mutagen-
esis, each residue was substituted for an alanine.
Replacement of the T709 residue with alanine abolished for-
skolin-stimulated 45Ca2 uptake, whereas mutation of S142
or S680 did not prevent the TRPV5 activation by forskolin
(Figure 4B). Again, forskolin stimulation of TRPV5-PKC6
did not differ from stimulation of TRPV5-WT (Figure 4B).
Importantly, TRPV5 protein expression was not affected by
the introduction of these mutations (Figure 4C). The essen-
tial role of T709 in forskolin-induced TRPV5 activation was
further supported by perforated patch analysis (Supple-
mental Figure 2) and FRET analysis (Figure 4D). Forskolin
significantly increased the intracellular Ca2 concentration
of cells expressing TRPV5-WT; however, no effect was ob-
served for TRPV5-T709A (Figure 4D). Likewise, TRPV5 ac-
tivation by PTH also required an intact T709 phosphoryla-
tion site (Supplemental Figure 3).
To confirm the crucial role of T709 in PKA-mediated
TRPV5 stimulation, we performed in vitro phosphorylation
experiments using the amino (N)- or carboxyl (C)-tail of
TRPV5 fused to glutathione S-transferase (GST). Proteins
were incubated for 30 min in the presence of [32P]ATP and
the purified catalytic subunit of PKA. Equal loading was veri-
fied by Coomassie staining, as shown in the Figure 4E, top.
Robust 32P-phosphorylation was detected for the GST C-tail,
whereas no radioactivity was present for the GST N-tail or for
GST alone (Figure 4E). In contrast to 32P labeling of GSTC-tail
harboring the S680Amutation, substitution of T709 by alanine
significantly reduced 32P labeling of the C-tail, confirming the
critical role of T709.
Molecular Mechanism of PKA-Induced TRPV5 Activity
We next addressed the molecular mechanism mediating the
rapid increase of TRPV5 activity upon forskolin treatment. To
Figure 4. Threonine 709 is necessary for forskolin-induced TRPV5 stimulation. (A) Localization of putative PKA phosphorylation sites
within several TRPV5 species. (B) Putative phosphorylation residues S142, S680, and T709 of TRPV5 were individually mutated into
alanine. 45Ca2 uptake of HEK293 cells expressing TRPV5-WT, TRPV5 point mutants, or TRPV5-PKC6 was conducted in the presence
of 25 M BAPTA-AM. *P 0.05 versus CTR. (C) Protein expression of TRPV5-WT and mutants. (D) Average calibrated FRET Ca2 levels
of TRPV5-WT (black trace, n 9) and TRPV5-T709A (gray trace, n 5), both stimulated with forskolin. (Inset) Comparison of basal Ca2
levels (time period “A”) and Ca2 levels after forskolin stimulation (“B”) of TRPV5-WT and TRPV5-T709A. *P  0.05 versus basal
conditions. (E) In vitro phosphorylation of TRPV5 N- and C-tail fused to GST. (Top) Protein input via Coomassie staining. (Bottom) 32P
radiation.
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this end, we pretreated HEK293 cells expressing TRPV5-WT
or TRPV5-T709A with 25 M BAPTA-AM, stimulated them
for 10 min with forskolin, and subjected them to cell surface
biotinylation. Cells were lysed, and biotinylated proteins were
precipitated with neutravidin-agarose beads. Using immuno-
blotting, TRPV5 expression in total cell lysates and plasma
membrane fraction was determined as depicted by Figure 5, A
and B, respectively. Forskolin treatment did not affect the cell
surface expression of TRPV5 (Figure 5B), suggesting that an
alteration in the single-channel activity of a fixed number of
channels is responsible for the PTH-mediated increase in
TRPV5 activity.
TRPV5 channel activity, therefore, was measured with the
cell-attached patch-clamp technique. Using HEK293 cells
transiently expressing TRPV5, we attached the patch pipette to
the cell without disrupting the membrane, and we recorded
TRPV5 channel current using Na as a charge carrier. As pre-
viously reported,32 virtually no channel activity was observed
at positive membrane potentials (Figure 6A). The current-
voltage (I-V) relationship established in response to a voltage
ramp from100 to 80 mV revealed an average single-channel
conductance of 90 11 pS (n 7). Such channel activity was
not present in nontransfected cells. Amplitude histogram anal-
ysis of the 80 mV recording revealed the presence of two
channels in the patch (Figure 6A). Having established a stable
recording of TRPV5 channel current at 80 mV, we added
forskolin to the bath solution. TRPV5 activity is represented by
averaged data of channel open probability (NPo, n number
of channels, Po open probability of channel) of 5-s intervals.
Forskolin application increased NPo values, which reached a
maximal effect 2min after addition (Figure 6B). Subsequently,
we compared mean NPo data during control conditions (min
0 to 1) and after forskolin addition (min 3 to 4). Representative
channel openings of TRPV5-WT and TRPV5-T709A are de-
picted in Figure 6, C and D, respectively. During control con-
ditions, channel activity of TRPV5-WT and TRPV5-T709A
was not significantly different; however, the number of
TRPV5-WT channel openings was increased during forskolin
treatment (Figure 6E), whereas TRPV5-T709A was not af-
fected (Figure 6F).
To investigate whether phosphorylation directly influences
TRPV5 single-channel activity, we used inside-out single-
channel patch-clamp analysis. Channel activity was restricted
to recordings at negative potentials (Figure 7A). From the cur-
rent-voltage (I-V) relationship, we calculated an average chan-
nel conductance of 39 2 pS. Amplitude histogram analysis of
the80 mV recording revealed the presence of a single chan-
nel in the patch (Figure 7A). The effect of PKA was tested at a
holding potential of 80 mV. After excision of the plasma
membrane, 1 mM ATP and 250 U/ml catalytic PKA were cu-
mulatively added to the patch-clamp recording chamber. Ap-
plication of the PKA subunit increased TRPV5-WT single-
channel activity (Figure 7, B and D), whereas TRPV5-T709A
single-channel activity was not significantly altered (Figure 7,
C and E).
DISCUSSION
This study delineates themolecularmechanism responsible for
TRPV5 channel activation by PTH.HEK293 cells coexpressing
TRPV5 and PTH1R demonstrated elevated cAMP levels upon
the addition of PTH and a subsequent increase in cytosolic
Ca2. This latter finding was due to enhanced TRPV5 activity.
Activation of the cAMP-PKA pathway, using PTH (1 to 31) or
forskolin, mimicked completely the PTH stimulation. Both
sufficient Ca2 buffering and PKA function were necessary for
this increased TRPV5-mediated Ca2 influx. A PKA-depen-
dent phosphorylation of T709 was found to be essential for
TRPV5 activation by PTH or forskolin. Finally, PTH-induced
TRPV5 activity was not due to an increase in the number of
functional channels at the plasma membrane but instead was
found to be the result of an enhanced single-channel open
probability of a fixed number of TRPV5 channels at the cell
surface.
To our knowledge, this is the first study providing a molec-
ular model linking the well-established role for cAMP-PKA
signaling after PTH1R engagement to the stimulation of Ca2
reabsorption from the pro-urine in the distal part of the
nephron. Whereas the majority of Ca2 reabsorption takes
place in the proximal tubule and thick ascending limb ofHenle
via passive paracellular transport, only approximately 15%
is actively reabsorbed in DCT and CNT33; however these last
two nephron segments control the renal excretion of Ca2
and are the target of PTH, which activates the cAMP signaling
Figure 5. Forskolin does not affect TRPV5 cell surface abun-
dance. Biotinylation studies were performed with HEK293 cells
expressing TRPV5 pretreated with BAPTA-AM to chelate intracel-
lular Ca2. (A and B) Forskolin had no effect on protein input (A)
or plasma membrane expression (B) of TRPV5-WT or TRPV5-
T709A.
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cascade, eventually enhancing Ca2 reabsorption.11,18,34,35
Use of the adenylyl cyclase–activating compound, forskolin,
and cell-permeable cAMP analogs in ex vivo models of ac-
tive Ca2 reabsorption mimicked the stimulatory effect of
PTH.11,17,19,20,36,37 Several studies suggested that PTH posi-
tively influences the uptake of Ca2 from the pro-urine,
although the specific protein mediating the apical influx of
Ca2 was unknown.5,17,18 In 1999, Hoenderop et al.38 iden-
tified TRPV5 as the apical uptake mechanism for active
Ca2 reabsorption in DCT and CNT. Functional analysis of
TRPV5 knockout mice supported this notion, because the
mean Ca2 delivery to puncturing sites in DCT was signif-
icantly higher than wild-type mice.13 These findings suggest
that TRPV5 is the molecular target of PTH-induced Ca2
reabsorption from the distal part of the nephron. Using
HEK293 cells coexpressing TRPV5 and PTH1R, we were
able to reproduce the cAMP-mediated stimulation of Ca2
influx upon the addition of PTH, as is observed in native
tissue (i.e., the kidney).
Buffering intracellular Ca2 was found to be crucial for an
increased TRPV5-mediated 45Ca2 influx by forskolin. Inter-
estingly, no additional buffer for Ca2was required for TRPV5
stimulation in the FRET assays. This is likely due to the Ca2-
chelating effect of calmodulin residing in the yellow cameleon
2.1.39 In contrast to EDTA-AM pretreatment, the addition of
BAPTA-AM increased 45Ca2 uptake of cells not stimulated
with forskolin. This finding is in line with the fast binding
kinetics of BAPTA comparedwith EDTA.29,40 Both EDTA-AM
andBAPTA-AMallowedTRPV5 activation by forskolin. Thus,
in contrast to other ion channels, fast Ca2 buffering is not
Figure 6. Forskolin stimulates TRPV5 chan-
nel activity. (A) Cell-attached single-channel
recordings were made from HEK293 cells ex-
pressing TRPV5-WT. Channel activity was
elicited by step potentials varying from 100
to 80 mV (left). The averaged calculated
slope conductance was 90 pS (top right). Am-
plitude histograms were constructed from re-
gions of the single-channel recordings ob-
tained at 80 mV (bottom right). The
histograms were fit by three Gaussian func-
tions corresponding to a closed, one open,
and two open levels. (B) Representative re-
cording of TRPV5-WT in time using cell-at-
tached patch-clamp (holding potential 80
mV). NPo values were the average of 5-s
intervals. (C and D) Representative channel
openings of TRPV5-WT (C) and TRPV5-T709A
(D) stimulated with forskolin. (E and F) Statis-
tical analysis demonstrates a significant ele-
vation for TRPV5-WT (n  8; E), whereas
TRPV5-T709A channel activity (n  8; F) was
not affected. *P  0.05 versus CTR.
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crucial for TRPV5 activity. Coexpression of calbindin-D28K
also buffered intracellular Ca2 sufficiently to permit forsko-
lin-induced TRPV5 stimulation. This Ca2-binding protein
specifically co-localizes with TRPV5 in DCT and CNT and has
been shown to play a crucial role in active Ca2 reabsorption in
vivo.31,41 At low intracellular Ca2 concentration, calbindin-
D28Kmoves to a position near the plasmamembrane and binds
directly to TRPV5. The associated calbindin-D28K tightly buff-
ers TRPV5-mediated Ca2 influx. Hereby, transcellular Ca2
transport is stimulated as TRPV5 inactivation is prevented by
the lowered intracellular Ca2 concentration.31 The observa-
tion that TRPV5 and calbindin-D28K co-localize to the apical
region of DCT and CNT supports our finding that acute
TRPV5 stimulation by PTH requires the local presence of a
Ca2-binding protein.
PKA plays a crucial role in forskolin-mediated TRPV5 acti-
vation. This is confirmed by the abolishment of TRPV5 stim-
ulation by H-89, a PKA blocker. The threonine at position 709
in TRPV5, a PKA consensus site, is essential for the activation
of TRPV5 by this mechanism, as demonstrated by 45Ca2 up-
take, FRET imaging, and patch-clamp analysis. In vitro, PKA
phosphorylation of the TRPV5 C-tail was virtually abolished
upon alanine substitution of T709. The remaining minor ra-
dioactive signal of the T709A mutant could possibly be due to
an additional PKA site. It is of interest that only the threonine
residue is completely conserved in all studied species, whereas
S142 and S680, the other putative phosphorylation sites, not
involved in forskolin-mediated TRPV5 activation, were absent
in nonmammalian species. Furthermore, amino acid align-
ment with the close homologue TRPV6 failed to reveal a con-
served putative PKA consensus site in proximity to TRPV5-
T709. Consistent with this, forskolin did not affect TRPV6
activity, confirming the specificity of TRPV5 activation. Inter-
estingly, PTH likely does not effect the intestinal absorption of
Ca2, in which TRPV6 is the proposed luminal influx mecha-
nism for Ca2.42
Figure 7. Isolated PKA catalytic subunit di-
rectly activates TRPV5-WT and not TRPV5-
T709A. (A) The plasma membrane was ex-
cised when channel activity was detected in
cell-attached configuration. Channel activity
was elicited by step potentials varying from
100 to 80 mV (left). Slope conductances of
TRPV5 channels were obtained from single-
channel current-voltage (I-V) relationship (top
right). Amplitude histogram of single-channel
recordings at 80 mV is shown (bottom
right). The histograms were fit by two Gauss-
ian functions corresponding to a closed and
one open level. (B and C) Representative cur-
rent traces from inside-out patch of
TRPV5-WT (B) and TRPV5-T709A (C) in re-
sponse to 80 mV holding potential. Inside-
out patch was performed in the presence of 1
mM ATP and isolated PKA catalytic subunit.
(D and E) Relative average NPo of TRPV5-WT
(n  7; D) was increased after PKA catalytic
subunit stimulation, whereas relative average
NPo of TRPV5-T709A (n  5; E) was not
significantly altered. *P  0.05 versus CTR.
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Using cell surface biotinylation assays and patch-clamp
analysis, the direct molecular mechanism responsible for
PTH-induced TRPV5 activation was elucidated. Because fors-
kolin-mediated PKA activation did not affect TRPV5 plasma
membrane expression, we studied single-channel activity in
the cell-attached and inside-out configuration. TRPV5 chan-
nel conductance (90 pS) in cell-attached patch-clamp analysis
was similar to our previously published values.32 In addition,
inside-out recordings revealed an average conductance of 39
pS, which is slightly lower than the previously reported val-
ues.32,43 In our collaborative study with Nilius et al.,32 we dem-
onstrated variability in the single-channel conductance rang-
ing from 55 to 95 pS. Use of different solutions and pH in the
individual reports might provide an explanation for the differ-
ences in channel conductance between these studies.43 Using
the cell-attached as well as inside-out configuration TRPV5
single-channel activitywas studied in response to forskolin and
the catalytic PKA subunit. A significant increase in TRPV5
open probability was measured in both configurations,
whereas channel activity of TRPV5-T709A was not altered.
Thus, our data suggest that PTH augments the open probabil-
ity of TRPV5 channels via a PKA-dependent phosphorylation,
which in turn results in an increased TRPV5-mediated Ca2
influx.
The stimulatory effect of PTH and forskolin on TRPV5 ac-
tivity in HEK293 cells was detected only at low intracellular
Ca2 concentrations. Thus, PKA-mediated TRPV5 stimula-
tion seems to rely on an unidentified Ca2-sensitive pathway.
To investigate further the role of intracellular Ca2 on TRPV5
stimulation by PKA, we initiated perforated patch-clamp re-
cordings. TRPV5 activity was determined by measuring the
whole-cell Na current. In contrast to the 45Ca2 uptake assay,
no additional Ca2 buffering was required to observe TRPV5
stimulation by forskolin. The absence of Ca2 influx via
TRPV5 in this latter patch-clamp configuration prevents an
increase in intracellular Ca2 concentration and therefore al-
lows stimulation of channel activity by forskolin. Subse-
quently, cells were treated with BAPTA-AM. In comparison
with the control condition, BAPTA-AM treatment did not sig-
nificantly increase the basal TRPV5-mediated Na current.
This indicates that under these conditions, the basal intracel-
lular Ca2 concentration does not inhibit TRPV5 activity;
however, BAPTA-AM pretreatment amplified the forskolin-
mediated stimulation of TRPV5. In a previous study per-
formed in MDCK cells stably expressing TRPV5, forskolin in-
creased TRPV5-mediated Ca2 influx without the presence of
an additional Ca2 buffer.44 Differences in basal Ca2 concen-
trations between TRPV5-expressing HEK293 andMDCK cells
might provide an explanation for this observation. Further re-
search is needed to identify the exact Ca2-sensitive pathway
preventing TRPV5 stimulation at increased intracellular Ca2
concentrations.
In addition to the Ca2-sensitive cAMP-PKA signaling
pathway, PTH has been reported to affect TRPV5 function via
othermolecularmechanisms.13,45 Several groups have demon-
strated that PKC is required for the PTH-mediated increase in
Ca2 reabsorption.12,46 Recently, Cha et al.16 confirmed the
crucial role of PLC-PKC signaling in PTH-induced TRPV5
stimulation. Activation of the PKC pathway reduced caveolae-
mediated TRPV5 endocytosis, resulting in an increased chan-
nel activity16; therefore, a 15-min pretreatment with PTH was
required. Furthermore, the TRPV5 channel lacking both PKC
phosphorylation sites did not respond to PTH.16 Interestingly,
in our experiments, PTH stimulation of the TRPV5 channel
missing these PKC sites was identical to TRPV5-WT. These
distinctive data might result from differences in the experi-
mental setup. Cha et al.16 applied 120 nM PTH for 15 min to
activate a PKC-signaling pathway, whereas we demonstrated
TRPV5 channel activity with 10 nM PTH within 5 min, sug-
gesting that moderate stimulation of PTH1R fully triggers the
cAMP-PKA pathway.
In 2005, van Abel et al.15 demonstrated that PTH upregu-
lates TRPV5 expression, which increases active Ca2 reabsorp-
tion via a long-term manner. Parathyroidectomized rats dis-
played a downregulation of TRPV5 protein expression,
whereas long-term PTH supplementation restored the expres-
sion. Thus, besides stimulating TRPV5 protein expression and
plasma membrane localization, PTH rapidly elevates TRPV5
channel activity, highlighting the essential role for PTH as the
in vivomediator of renal Ca2 sparing.
Altogether, our results suggest that TRPV5 is the molecular
target for the rapid PTH-induced stimulation of active Ca2
reabsorption in the distal part of the nephron. Activation of
PTH1R initiates a signaling pathway, which involves cAMP
andPKA that eventually results in the phosphorylation of thre-
onine 709 and a subsequent increase in TRPV5 single-channel
activity.
CONCISE METHODS
Molecular Biology and Cell Culture
Constructs containing TRPV5, TRPV6, or calbindin-D28K in
pCINeo/IRES-GFP were obtained as described previously.47 Single
PKAmutants were generated by alanine substitution of the threonine
and serine residues of putative phosphorylation sites of TRPV5
(S142A, S680A, and T709A) using in vitro mutagenesis. TRPV5 N-
and C-tail were cloned into the pGEX 6p-2 vector; subsequently, the
previously described putative phosphorylation sites of TRPV5 were
mutated into an alanine. The FRET sensor for Ca2 (yellow cameleon
2.1) was a gift of Dr. Tsien (University of California, San Diego, La
Jolla, CA). FRET sensors for cAMP, CFP-Epac-YFP,25 PIP2, eCFP-
PH1, and eYFP1 were generated as described previously.24 For the
combined use of TRPV5 and both FRET sensors, IRES-GFP was re-
moved from the original pCINEO/IRES-GFP vector. The PTH1Rwas
a gift of Dr. Silver (Jerusalem, Israel). HEK293 cells were grown and
transfected as described previously.48 HEK293 cells stably expressing
TRPV5 were generated as described previously44 and maintained in
medium containing 400 g/ml G418.
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45Ca2 Uptake
Radioactive Ca2 uptake was determined using TRPV5- and TRPV6-
expressing HEK293 cells seeded in poly-L-lysine–coated (Sigma, St.
Louis, MO) 24-well plates. Cells were pretreated for 30 min with 25
MBAPTA-AM or 25 MEDTA-AM, subsequently incubated for 5
min in KHB buffer (110 mM NaCl, 5 mM KCl, 1.2 mM MgCl2, 0.1
mMCaCl2, 10 mMNa-acetate, 2 mMNaH2PO4, and 20 mMHEPES
[pH 7.4]-NaOH), and finally incubated for 10 min with 45CaCl2 (1
Ci/ml) in KHB buffer with voltage-gated Ca2 channel inhibitors
(10 M felodipine and 10 M verapamil). For blocking of TRPV5-
mediated 45Ca2 uptake, cells were incubated with 10Mruthenium
red during the 5- and 10-min incubation steps. After multiple wash-
ing steps with ice-cold stop buffer (110mMNaCl, 5mMKCl, 1.2mM
MgCl2, 10mMNa-acetate, 0.5mMCaCl2, 1.5mMLaCl3, and 20mM
HEPES [pH 7.4]-NaOH), the uptake of 45Ca2 was measured.
Cell Surface Biotinylation and Immunoblotting
HEK293 cells stably expressing TRPV5 were seeded on poly-L-lysine–
coated 10-cm dishes and treated similar as 45Ca2 uptake assay. After
10 min of incubation with forskolin or ethanol (solvent) as a control,
cells were placed on ice to inhibit intracellular trafficking processes.
Subsequent biotinylation was performed on ice using 0.5 mg/ml
sulfo-NHS-LC-LC-biotin (Pierce, Etten-leur, Netherlands) in PBS
supplemented with 0.5 mMCaCl2 and 1.0 mMMgCl2 (PBS-CM) for
30 min. Unbound biotin was quenched with 0.1% (wt/vol) BSA in
PBS-CM. Finally, cells were washed with PBS-CM and PBS and lysed
in 150 mM NaCl, 5 mM EDTA, 50 mM Tris-HCl (pH 7.5), 1%
(vol/vol) NP-40, 1 mM PMSF, 10 g/ml leupeptin, and 10 g/ml
pepstatin A at 4°C. The lysate was centrifuged at 16,000 	 g, and
biotinylated proteins were precipitated via neutravidin-coupled
beads (Pierce) and analyzed by immunoblot using anti-TRPV5 anti-
body.
GST Pull-down and In Vitro Phosphorylation
TRPV5 C- and N-tails fused to GST were purified as described previ-
ously.49 The precipitated fusion proteins, immobilized on glutathione
Sepharose 4B beads, were incubated for 30 min at 30°C in kinase
reaction buffer (50 mM Tris-HCl [pH 7.5], 10 mM MgCl2, and 100
MATP) containing the catalytic subunit of PKA (100 U/l reaction
buffer;NewEnglandBiolabs, Leusden, TheNetherlands) and 2Ci of
[32P]ATP. For removing unbound [32P]ATP, the beads were
washed three times with 50 mM HEPES (pH 7.4)-KOH, 4 mM
MnCl2, and 0.5 mM CaCl2. Proteins were eluted with SDS-PAGE
loading buffer and separated on SDS-polyacrylamide gel, and in vitro
phosphorylation was analyzed by autoradiography.
Dynamic FRET Assays
Cells grown on glass coverslips (diameter 24 mm) were transfected
with FRET constructs (1 g per coverslip), and experiments were
performed as described previously.24,25 In brief, coverslips were
placed on an inverted Nikon microscope (Du¨sseldorf, Germany) and
excited at 425 nm using an ND3 filter. CFP and YFP emission was
collected simultaneously through 470 20- and 530 25-nm band-
pass filters. Data were acquired at two samples per second, and FRET
was expressed as ratio of CFP to YFP signals. Calibration of CFP/YFP
was accomplished by assessment of upper and lower saturation levels
of the FRET sensors, resulting in 
FRET.
Electrophysiology
Patch-clamp experiments in the single-channel mode and perforated
whole-cell configuration were performed as described previously32 at
room temperature using an EPC-9 patch-clamp amplifier computer
controlled by the Pulse software (HEKA Elektronik, Lambrecht, Ger-
many). For single-channel measurements in cell-attachedmode, cells
were perfusedwith the following solution: 140mMKCl, 5mMEDTA,
5 mM EGTA, 1 mMMgCl2, 10 mM glucose, and 10 mMHEPES (pH
7.2)-KOH. For inside-out patches, excision was done in the same
solution and 1 mM ATP was added. In both configurations, the pi-
pette contained 140 mM NaCl, 10 mM EGTA, and 10 mM HEPES
(pH7.2)-NaOH. The sampling rate was 10 kHz; currents were filtered
at 1 kHz. The analysis of single-channel data was performed using
TAC software (Bruxton, Seattle, WA). Perforated whole-cell patch-
clamp analysis was performed as described previously.50 For perfo-
rated patch recordings, 0.6 mg/ml of the pore-forming agent ampho-
tericin B was added to the following pipette solution: 100 mM Cs-
Aspartate, 20 mM CsCl, 1 mMMgCl2, and 10 mMHEPES (pH 7.2)-
CsOH. Cells were kept and recorded in nominal divalent-free
solution containing 150 mM NaCl, 6 mM CsCl, 1 mM CaCl2, 1 mM
MgCl2, 10 mM HEPES, and 10 mM glucose (pH 7.4)-NaOH. The
action of amphotericin B was visible as a continuous decrease in serial
resistance. Recordings were started when the serial resistance attained
values below 15 M. BAPTA-AM (100 M) was used to chelate in-
tracellular free Ca2, after which forskolin (10 M) was added. Per-
forated whole-cell data were analyzed using Igor pro software (Wave-
metrics, Lake, Oswego, OR).
Compounds
Full-length humanPTH, humanPTH (1 to 31), and bovine PTH (3 to
34) were purchased fromBachemAG (Bubendorf, Switzerland). For-
skolin, amphotericin B, and the PKA inhibitor H-89 were purchased
from Sigma.
Statistical Analysis
In all experiments, data are expressed as means  SEM. Overall sta-
tistical significance was determined by ANOVA. In case of signifi-
cance, differences between the means of two groups were analyzed by
paired and unpaired t test. P 0.05 was considered significant.
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